1. Home
  2. GGN vs MGTX Comparison

GGN vs MGTX Comparison

Compare GGN & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GAMCO Global Gold Natural Resources & Income Trust

GGN

GAMCO Global Gold Natural Resources & Income Trust

N/A

Current Price

$5.06

Market Cap

820.2M

Sector

Finance

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$9.26

Market Cap

881.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GGN
MGTX
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
820.2M
881.7M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
GGN
MGTX
Price
$5.06
$9.26
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
429.7K
★ 607.2K
Earning Date
01-01-0001
11-12-2026
Dividend Yield
★ 10.26%
N/A
EPS Growth
N/A
★ 33.02
EPS
N/A
★ 0.68
Revenue
N/A
★ $81,391,000.00
Revenue This Year
N/A
$314.19
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$12.97
Revenue Growth
N/A
★ 144.57
52 Week Low
$4.69
$6.62
52 Week High
$5.88
$15.35

Technical Indicators

Market Signals
Indicator
GGN
MGTX
Relative Strength Index (RSI) 41.73 43.56
Support Level $5.01 $8.80
Resistance Level $5.13 $10.08
Average True Range (ATR) 0.08 0.53
MACD 0.01 0.08
Stochastic Oscillator 23.75 49.03

Price Performance

Historical Comparison
GGN
MGTX

About GGN GAMCO Global Gold Natural Resources & Income Trust

GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest the majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: